Shetal Vyas

Vice President, Operations

Shetal Vyas is responsible for Ferring Operations which includes Commercial Operations, Communications, Customer Engagement, Market Access and Sales Training.

Shetal has 20 years of experience in the pharmaceutical industry. She joined Ferring in 2019 as leader of the Gastroenterology and Urology Business Unit. Prior to Ferring, she was vice president of marketing at Pentec Health, Inc. Shetal began her career in sales at AstraZeneca where she rose to positions of increasing responsibility.

Shetal holds an MBA in Marketing from St. Joseph’s University in Philadelphia and a Bachelor of Science in Health Studies from Temple University also in Philadelphia.

This site contains material about Ferring Pharmaceuticals Inc. (hereinafter "Ferring") and its various products that may be of interest to Ferring's employees and customers, as well as to members of the health care community and the general public. Please feel free to browse this web site. Your access and use of the information contained herein is subject to the following terms and conditions and all applicable laws. By accessing and browsing this web site, you accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede any other agreement between you and Ferring.

All information on this site is intended for US audiences only.

CERVIDIL, CLENPIQ, ENDOMETRIN, EUFLEXXA, FIRMAGON, MENOPUR, NOCDURNA, NOVAREL, and ZOMACTON are registered trademarks of Ferring B.V. INVOCELL is a registered trademark of INVO BioScience. ORTIKOS is a trademark of Sun Pharma Global FZE.

©2008-2020 Ferring Pharmaceuticals.  US-CORP-2100028